P. Bus

Complement Activation in Patients With Diabetic Nephropathy

R. Wolterbeek, L. Trouw, H. Baelde, 2017, Kidney international reports.

Apolipoprotein C‐I plays a role in the pathogenesis of glomerulosclerosis

R. Wolterbeek, H. Baelde, Emile de Heer, 2017, The Journal of pathology.

Endoglin Mediates Vascular Endothelial Growth Factor-A-Induced Endothelial Cell Activation by Regulating Akt Signaling.

R. Wolterbeek, H. Baelde, J. Bruijn, 2018, The American journal of pathology.

Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes

H. Baelde, J. Bruijn, M. Scharpfenecker, 2020, Scientific reports.

The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes

R. Wolterbeek, H. Baelde, J. Bruijn, 2017, Diabetologia.

The VEGF Inhibitor Soluble FLT-1 Ameliorates Atopic Dermatitis in APOC1 Transgenic Mice.

H. Baelde, J. Bruijn, J. Berbée, 2020, The Journal of investigative dermatology.